May 11, 2017 - Teva???s first quarter earnings (including equity compensation expenses), came in at $1.03 per share, in-line with the consensus estimate.
May 11, 2017 - The following slide deck was published by Teva Pharmaceutical Industries Limited in conjunction with their 2017 Q1 earnings call.
May 11, 2017 - Names on the move ahead of the open.
May 10, 2017 - From Copaxone's patents to its $35.8 billion in debt, shareholders have questions and we want answers.
May 09, 2017 - Mylan and Teva are scheduled to report on May 10 and May 11
May 09, 2017 - Allergan plc's (AGN) first-quarter 2017 earnings came in at $3.35 per share, beating the Zacks Consensus Estimate of $3.32 by 0.9%.
May 08, 2017 - Express Scripts is partnering with a California-based drug discount program to launch Inside Rx, a new subsidiary focused on lowering out-of-pocket costs for prescription medications.
Inside Rx, which is partially owned by Express Scripts, will deliver average savings of 34 percent on prescription drugs for those who do not have insurance or have plans with high deductibles, according to an announcement about the program. Express Scripts is teaming up with Santa Monica, California-based GoodRx on…
May 08, 2017 - Teva Pharmaceutical Industries Ltd. (TEVA) is scheduled to report first-quarter 2017 earnings on May 11
May 08, 2017 - Major pharma companies like Pfizer (PFE) and Merck reported Q1 results last week.
May 04, 2017 - Beleaguered Teva shares appear to have 'playable' support at around $30. While the upcoming earnings report of May 11 may be bad, bad enough to break that support, entry at this level for the long ter